Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by ANALIAS00on Feb 09, 2018 2:44pm

151 Views

Post# 27535355

RE:Who will be the lucky buyers?

I bought 1000 at $6.75, my order had more but only 1000 went through at that price. So a quick 3.7% but to be honnest, but at $7.00 now, not sure if I should smile or cry :o( :o)

I said that before, soon I will be the one needing drugs to handle the stress of this adventure :)

Cant wait for the day we will not only smile but laught about it. And count on me to be at peel pub for the first and the last round of beer !!

Bullboard Posts

Pro Women’s Hockey League comes to NHL 25 in December